Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor-Suppressing Pathways in Cystic Pancreatic Tumors

1 Jan 2003

Abstract excerpt

INTRODUCTION AND AIMS: Serous and mucinous cystic pancreatic tumors have different clinical behavior. We evaluated whether they also have genotypic differences by analyses of the tumor suppressor genes, p16INK4a, p53, and DPC4. METHODOLOGY: Seven serous cystadenomas (SCA) and seven malignant mucinous cystadenocarcinomas (MCC) were analyzed for alterations in the tumor suppressor genes p16INK4a, p53, and DPC4 by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic and Kidney Cyst Diseases
Share to Pancreatic and Hepatic Oncology Research
Share to Renal and related cancers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12499916
DOI: 10.1097/00006676-200301000-00008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor-Suppressing Pathways in Cystic Pancreatic TumorsPMID 12499916Read ↗

Abnormalities of tumor suppressor gene p16 in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters.Semantic proximity Read ↗

Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas.Semantic proximity Read ↗

Alterations of tumor suppressor gene p16INK4a in pancreatic ductal carcinoma.Semantic proximity Read ↗

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.Semantic proximity Read ↗

Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.Semantic proximity Read ↗

Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine NeoplasmsSemantic proximity Read ↗

Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance.Semantic proximity Read ↗

Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Frequent p16INK4A/CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors.Semantic proximity Read ↗

Promoter methylation of <i>p16</i><sup><i>INK4a</i></sup>, <i>RASSF1A</i>, and <i>DAPK</i> is frequent in salivary adenoid cystic carcinomaSemantic proximity Read ↗

Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.Semantic proximity Read ↗

Histology of cystic tumors of the pancreas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.